I-MAB/$NBP
14:30
22:10
05:45
13:25
21:00
1D1W1MYTD1Y5YMAX
About I-MAB
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.
Ticker
$NBP
Sector
Primary listing
Employees
32
Headquarters
Website
I-MAB Metrics
BasicAdvanced
$460M
-
-$0.49
1.46
-
Price and volume
Market cap
$460M
Beta
1.46
52-week high
$6.79
52-week low
$0.60
Average daily volume
487K
Financial strength
Current ratio
22.817
Quick ratio
22.542
Long term debt to equity
1.336
Total debt to equity
1.769
Profitability
EBITDA (TTM)
-38.085
Management effectiveness
Return on assets (TTM)
-10.36%
Return on equity (TTM)
-18.46%
Valuation
Price to book
1.66
Price to tangible book (TTM)
1.66
Price to free cash flow (TTM)
7.475
Free cash flow yield (TTM)
13.38%
Free cash flow per share (TTM)
0.534
Growth
Earnings per share change (TTM)
-56.40%
3-year earnings per share growth (CAGR)
-50.34%
What the Analysts think about I-MAB
Analyst ratings (Buy, Hold, Sell) for I-MAB stock.
I-MAB Financial Performance
Revenues and expenses
I-MAB Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for I-MAB stock?
I-MAB (NBP) has a market cap of $460M as of December 15, 2025.
What is the P/E ratio for I-MAB stock?
The price to earnings (P/E) ratio for I-MAB (NBP) stock is 0 as of December 15, 2025.
Does I-MAB stock pay dividends?
No, I-MAB (NBP) stock does not pay dividends to its shareholders as of December 15, 2025.
When is the next I-MAB dividend payment date?
I-MAB (NBP) stock does not pay dividends to its shareholders.
What is the beta indicator for I-MAB?
I-MAB (NBP) has a beta rating of 1.46. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.